Alx Oncology Holdings Inc (ALXO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8301 -0.0013 (-0.16%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8701 +0.0400 (+4.82%) 17:58 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 33,789 | 24,747 | 28,472 | 24,576 | 16,299 |
| Operating Income | -33,789 | -24,747 | -28,472 | -24,576 | -16,299 |
| Interest Expense | 2 | 3 | 0 | 0 | 0 |
| Other Income | 871 | 217 | 13 | 10 | 25 |
| Pre-tax Income | -32,920 | -24,533 | -28,459 | -24,566 | -16,274 |
| Net Income Continuous | -32,920 | -24,533 | -28,438 | -24,566 | -16,274 |
| Net Income | $-32,920 | $-24,533 | $-28,438 | $-24,566 | $-16,274 |
| EPS Basic Total Ops | -0.81 | -0.60 | -0.71 | -0.61 | -0.40 |
| EPS Basic Continuous Ops | -0.81 | -0.60 | -0.70 | -0.61 | -0.40 |
| EPS Diluted Total Ops | -0.81 | -0.60 | -0.71 | -0.61 | -0.40 |
| EPS Diluted Continuous Ops | -0.81 | -0.60 | -0.70 | -0.61 | -0.40 |
| EBITDA(a) | $-33,709 | $-24,582 | $-28,438 | $-24,570 | $-16,293 |